Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
BMC Infectious Diseases|January 5, 2011
Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosisPayam Nahid, Leah G Jarlsberg, Irina Rudoy, et al.
American Journal of Respiratory and Critical Care Medicine|February 10, 2007
Treatment outcomes of patients with HIV and tuberculosisPayam Nahid, Leah C Gonzalez, Irina Rudoy, et al.
American Journal of Respiratory and Critical Care Medicine|September 21, 2010
Integrated strategies to optimize sputum smear microscopy: a prospective observational studyAdithya Cattamanchi, Laurence Huang, William Worodria, et al.
Annals of Internal Medicine|October 16, 2002
Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a multicenter clinical trialRobert M Jasmer, Jussi J Saukkonen, Henry M Blumberg, et al.
Expert Review of Anti-Infective Therapy|May 2, 2023
Updated considerations in the diagnosis and management of tuberculosis infection and disease: integrating the latest evidence-based strategiesDaniel S Graciaa, Marcos Coutinho Schechter, Krystle B Fetalvero, et al.
Lancet (London, England)|May 22, 2010
Tuberculosis control and elimination 2010-50: cure, care, and social developmentKnut Lönnroth, Kenneth G Castro, Jeremiah Muhwa Chakaya, et al.
Plos One|May 28, 2010
Influence of M. tuberculosis lineage variability within a clinical trial for pulmonary tuberculosisPayam Nahid, Erin E Bliven, Elizabeth Y Kim, et al.
Archives of Internal Medicine|December 12, 2007
Trends in tuberculosis/human immunodeficiency virus comorbidity, United States, 1993-2004Rachel Albalak, Richard J O'Brien, J Steve Kammerer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 13, 2009
Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from BotswanaSekai Chideya, Carla A Winston, Charles A Peloquin, et al.
American Journal of Respiratory and Critical Care Medicine|May 30, 2014
Impact of GeneXpert MTB/RIF on patients and tuberculosis programs in a low-burden setting. a hypothetical trialJ Lucian Davis, L Masae Kawamura, Lelia H Chaisson, et al.
Pageof 11